Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism
Open Access
- 8 March 1999
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 159 (5) , 457-460
- https://doi.org/10.1001/archinte.159.5.457
Abstract
CURRENTLY, the range of indications for the use of anticoagulant therapy is steadily growing. There is now evidence from clinical trials that anticoagulant therapy is effective in the primary and secondary prevention of thromboembolic complications in patients with atrial fibrillation, prosthetic heart valves, cardioembolic ischemic cerebral disease, myocardial infarction, and venous thromboembolism (VTE).1This publication has 9 references indexed in Scilit:
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 1995
- Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, MinnesotaMayo Clinic Proceedings, 1995
- Anticoagulant-related bleeding: Clinical epidemiology, prediction, and preventionThe American Journal of Medicine, 1993
- Risk Factors for Complications of Chronic Anticoagulation: A Multicenter StudyAnnals of Internal Medicine, 1993
- A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1990
- Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapyThe American Journal of Medicine, 1987
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983